Condition
FBN1, TGFBR1, TGFBR2, ACTA2 or MYH11 Genetic Mutation
Total Trials
1
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Related Conditions
Often studied with 11 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Active Sponsors
- National Heart, Lung, and Blood Institute (NHLBI)1
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1
Top Investigators
Johns Hopkins University
RTI International
University of Texas Medical School at Houston
Oregon Health and Science University
University of Michigan
Related Conditions
- Bicuspid Aortic Valve With Coarctation1
- Shprintzengoldberg Syndrome1
- Bicuspid Aortic Valve Without Known Family History1
- Other Aneurdiss Of Thoracic Aorta Not Due To Trauma 50yo1
- Loeysdietz Syndrome1